Fig 1: Correlation Analysis between MPO and Related Routine Test Indicators: A: MPO has a positive correlation with CSF-IL-6 content (R2 = 0.8293, P < 0.0001); B: MPO has a positive correlation with CSF-IL-8 (R2 = 0.8363, P < 0.0001); C: MPO has a positive correlation with CSF-IL-18 (R2 = 0.8315, P < 0.0001); D: MPO has a positive correlation with CSF-TNF-α (R2 = 0.8733, P < 0.0001); E: MPO has a positive correlation with CSF-IL-1β (R2 = 0.8389, P < 0.0001)
Fig 2: Differential analysis of relevant indicators between poor prognosis group and good prognosis group (A) differential analysis of CSF-MPO (B) differential analysis of CSF-IL6 (C) Differential analysis of CSF-IL8 (D) differential analysis of CSF-IL18 (E) differential analysis of CSF-IL1β (F) differential analysis of CSF-TNFα nsP > 0.05; ****P < 0.0001; ***P < 0.0002; **P < 0.0021; *P < 0.0332
Fig 3: ROC curve. The Receiver Operating Characteristic (ROC) curves for Cerebrospinal Fluid (CSF) levels of Interleukin CSF-IL-1β, CSF-IL-6, CSF-IL-8, CSF-IL-18, CSF-MPO, and Tumor Necrosis Factor CSF-TNF-α at cutoff values of 3.83pg/mL, 123.92pg/mL, 4230.62pg/mL, 35.55pg/mL, 16.57ng/mL, and 35.19pg/mL, respectively
Supplier Page from CUSABIO Technology LLC for Human myeloperoxidase,MPO ELISA Kit